Gene · 710
Papers4,575
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,041 to 2,060 of 4,575
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Oral plasma kallikrein inhibitor BCX7353 for treatment of hereditary angioedema. | Immunotherapy | 2019 | 31635497 | PubTator, text mining | PubMed |
| Therapeutic Modulation of the Complement System in Kidney Transplantation: Clinical Indications and Emerging Drug Leads. | Front Immunol | 2019 | 31632397 | PubTator, text mining | PubMed |
| Classical pathway activity C3c, C4 and C1-inhibitor protein reference intervals determination in EDTA plasma. | Biochem Med (Zagreb) | 2019 | 31624460 | PubTator, text mining | PubMed |
| Upregulation of C1-inhibitor in pancreatic cancer. | Oncotarget | 2019 | 31620245 | PubTator, text mining | PubMed |
| A hereditary angioedema screening in two villages, based on an index case, and identification of a novel mutation, "1033G>T", at the SERPING1 gene. | Postepy Dermatol Alergol | 2019 | 31616213 | PubTator, text mining | PubMed |
| Bradykinin-Mediated Angioedema: An Update of the Genetic Causes and the Impact of Genomics. | Front Genet | 2019 | 31611908 | PubTator, text mining | PubMed |
| Complement Inhibitors in Clinical Trials for Glomerular Diseases. | Front Immunol | 2019 | 31611870 | PubTator, text mining | PubMed |
| DNA methylome-wide alterations associated with estrogen receptor-dependent effects of bisphenols in breast cancer. | Clin Epigenetics | 2019 | 31601247 | PubTator, text mining | PubMed |
| Dual function of miR-1248 links interferon induction and calcium signaling defects in Sjögren's syndrome. | EBioMedicine | 2019 | 31597594 | PubTator, text mining | PubMed |
| Management of patients with hereditary angio-oedema in dental, oral, and maxillofacial surgery: a review. | Br J Oral Maxillofac Surg | 2019 | 31591028 | PubTator, text mining | PubMed |
| A Case of Acquired Angioedema with Low C1 Inhibitor (C1-INH) Associated with Splenic Marginal Zone Lymphoma. | Am J Case Rep | 2019 | 31588119 | PubTator, text mining | PubMed |
| Self-administration of icatibant in acute attacks of Type I hereditary angioedema: A case report and review of hereditary angioedema. | Dermatol Ther | 2019 | 31579975 | PubTator, text mining | PubMed |
| A novel SERPING1 gene variant causing angioedema in a patient with low C1q levels. | Ann Allergy Asthma Immunol | 2019 | 31568857 | PubTator, text mining | PubMed |
| SWATH-based proteomics reveals processes associated with immune evasion and metastasis in poor prognosis colorectal tumours. | J Cell Mol Med | 2019 | 31560832 | PubTator, text mining | PubMed |
| Comparison of Gene Expression Responses in the Small Intestine of Mice Following Exposure to 3 Carcinogens Using the S1500+ Gene Set Informs a Potential Common Adverse Outcome Pathway. | Toxicol Pathol | 2019 | 31558096 | PubTator, text mining | PubMed |
| Proteomic Biomarkers of Retinal Inflammation in Diabetic Retinopathy. | Int J Mol Sci | 2019 | 31557880 | PubTator, text mining | PubMed |
| Platelets and Complement Cross-Talk in Early Atherogenesis. | Front Cardiovasc Med | 2019 | 31555668 | PubTator, text mining | PubMed |
| Altered Expression of Complement Regulatory Proteins CD35, CD46, CD55, and CD59 on Leukocyte Subsets in Individuals Suffering From Coronary Artery Disease. | Front Immunol | 2019 | 31555286 | PubTator, text mining | PubMed |
| Systematic Review of Safety and Efficacy of Rituximab in Treating Immune-Mediated Disorders. | Front Immunol | 2019 | 31555262 | PubTator, text mining | PubMed |
| Clinical Features and Outcomes Associated with Angioedema in the Emergency Department. | West J Emerg Med | 2019 | 31539333 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/papers?page=103